Industry Growth Insights published a new data on “CRISPR Gene Editing Market”. The research report is titled “CRISPR Gene Editing Market research by Types (gRNA Design and Vector Construction, Cell Line and Engineering, Screening Services, Others), By Applications (Agricultural, Biomedical, Industrial, Others), By Players/Companies Abcam, Inc., Applied StemCell, Inc., Cellecta, Inc., CRISPR Therapeutics AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group PLC, Integrated DNA Technologies, Inc., Merck KGaA, New England Biolabs, Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
CRISPR Gene Editing Market Research Report
By Type
gRNA Design and Vector Construction, Cell Line and Engineering, Screening Services, Others
By Application
Agricultural, Biomedical, Industrial, Others
By Companies
Abcam, Inc., Applied StemCell, Inc., Cellecta, Inc., CRISPR Therapeutics AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group PLC, Integrated DNA Technologies, Inc., Merck KGaA, New England Biolabs, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
126
Number of Tables & Figures
89
Customization Available
Yes, the report can be customized as per your need.
Global CRISPR Gene Editing Market Report Segments:
The global CRISPR Gene Editing market is segmented on the basis of:
Types
gRNA Design and Vector Construction, Cell Line and Engineering, Screening Services, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Agricultural, Biomedical, Industrial, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam, Inc.
- Applied StemCell, Inc.
- Cellecta, Inc.
- CRISPR Therapeutics AG
- GeneCopoeia, Inc.
- GenScript Biotech Corporation
- Horizon Discovery Group PLC
- Integrated DNA Technologies, Inc.
- Merck KGaA
- New England Biolabs, Inc.
Highlights of The CRISPR Gene Editing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- gRNA Design and Vector Construction
- Cell Line and Engineering
- Screening Services
- Others
- By Application:
- Agricultural
- Biomedical
- Industrial
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the CRISPR Gene Editing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
CRISPR is a gene editing technology that uses an enzyme called Cas9 to cut DNA. CRISPR can be used to edit genes in any organism, including humans. CRISPR can be used to change the genetic makeup of cells in vitro or in vivo.
Some of the major players in the crispr gene editing market are Abcam, Inc., Applied StemCell, Inc., Cellecta, Inc., CRISPR Therapeutics AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group PLC, Integrated DNA Technologies, Inc., Merck KGaA, New England Biolabs, Inc..
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 CRISPR Gene Editing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 CRISPR Gene Editing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 CRISPR Gene Editing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the CRISPR Gene Editing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global CRISPR Gene Editing Market Size & Forecast, 2018-2028
4.5.1 CRISPR Gene Editing Market Size and Y-o-Y Growth
4.5.2 CRISPR Gene Editing Market Absolute $ Opportunity
Chapter 5 Global CRISPR Gene Editing Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 CRISPR Gene Editing Market Size Forecast by Type
5.2.1 gRNA Design and Vector Construction
5.2.2 Cell Line and Engineering
5.2.3 Screening Services
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global CRISPR Gene Editing Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 CRISPR Gene Editing Market Size Forecast by Applications
6.2.1 Agricultural
6.2.2 Biomedical
6.2.3 Industrial
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global CRISPR Gene Editing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 CRISPR Gene Editing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America CRISPR Gene Editing Analysis and Forecast
9.1 Introduction
9.2 North America CRISPR Gene Editing Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America CRISPR Gene Editing Market Size Forecast by Type
9.6.1 gRNA Design and Vector Construction
9.6.2 Cell Line and Engineering
9.6.3 Screening Services
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America CRISPR Gene Editing Market Size Forecast by Applications
9.10.1 Agricultural
9.10.2 Biomedical
9.10.3 Industrial
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe CRISPR Gene Editing Analysis and Forecast
10.1 Introduction
10.2 Europe CRISPR Gene Editing Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe CRISPR Gene Editing Market Size Forecast by Type
10.6.1 gRNA Design and Vector Construction
10.6.2 Cell Line and Engineering
10.6.3 Screening Services
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe CRISPR Gene Editing Market Size Forecast by Applications
10.10.1 Agricultural
10.10.2 Biomedical
10.10.3 Industrial
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific CRISPR Gene Editing Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific CRISPR Gene Editing Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific CRISPR Gene Editing Market Size Forecast by Type
11.6.1 gRNA Design and Vector Construction
11.6.2 Cell Line and Engineering
11.6.3 Screening Services
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific CRISPR Gene Editing Market Size Forecast by Applications
11.10.1 Agricultural
11.10.2 Biomedical
11.10.3 Industrial
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America CRISPR Gene Editing Analysis and Forecast
12.1 Introduction
12.2 Latin America CRISPR Gene Editing Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America CRISPR Gene Editing Market Size Forecast by Type
12.6.1 gRNA Design and Vector Construction
12.6.2 Cell Line and Engineering
12.6.3 Screening Services
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America CRISPR Gene Editing Market Size Forecast by Applications
12.10.1 Agricultural
12.10.2 Biomedical
12.10.3 Industrial
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) CRISPR Gene Editing Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) CRISPR Gene Editing Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) CRISPR Gene Editing Market Size Forecast by Type
13.6.1 gRNA Design and Vector Construction
13.6.2 Cell Line and Engineering
13.6.3 Screening Services
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) CRISPR Gene Editing Market Size Forecast by Applications
13.10.1 Agricultural
13.10.2 Biomedical
13.10.3 Industrial
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 CRISPR Gene Editing Market: Competitive Dashboard
14.2 Global CRISPR Gene Editing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam, Inc.
14.3.2 Applied StemCell, Inc.
14.3.3 Cellecta, Inc.
14.3.4 CRISPR Therapeutics AG
14.3.5 GeneCopoeia, Inc.
14.3.6 GenScript Biotech Corporation
14.3.7 Horizon Discovery Group PLC
14.3.8 Integrated DNA Technologies, Inc.
14.3.9 Merck KGaA
14.3.10 New England Biolabs, Inc.
